Evaluation of GLUT1, IGF-2, VEGF, FGF 1, and angiopoietin 2 in infantile hemangioma - 04/05/21
, Ahmet Ufuk Kömüroğlu b, Adem Yasin Köksoy c, Ülkü Gül Şiraz c, Emine Tekin c, Alper Köker dBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Introduction |
Infantile hemangioma (IH) is a common vascular tumor in children. It is reported that IHs are associated with immunochemical markers such as vascular endothelial growth factor (VEGF)-A, glucose transporter isoform 1 (GLUT1), and insulin-like growth factor-2 (IGF-2).
Material and methods |
This cross-sectional study focused on pediatric patients with IH. A total of 46 patients (mean age 14.2±21.9 months) with IH and 45 healthy controls (mean age 21.8±15.08 months) were enrolled. Demographic data, clinical findings, and laboratory parameters were recorded. Blood samples were collected. Serum GLUT1, IGF-2, VEGF-A, fibroblast growth factor 1 (FGF1), and angiopoietin 2 levels were assessed by enzyme-linked immunosorbent assay.
Results |
Serum GLUT1, IGF-2, and VEGF-A levels were significantly higher in patients with IH than in healthy controls (8.80±4.07pg/mL vs. 5.66±4.34pg/mL, 281.10±84.12pg/mL vs. 234.19±75.38pg/mL, 1196.99±389.34pg/mL vs. 996.99±349.16pg/mL, respectively, p=0.026, p=0.030, and p=0.036). Serum GLUT1, IGF-2, and VEGF-A levels in patients with complicated hemangioma were significantly higher than in healthy controls (9.69±3.94pg/mL vs. 5.66±4.34pg/mL, 289.94±83.18pg/mL vs. 234.19±75.38pg/mL, 1276.22±388.24pg/mL vs. 996.99±349.16pg/mL, respectively, p=0.017, p=0.022, and p=0.011). Serum GLUT1, IGF-2, and VEGF-A levels in patients with hemangioma receiving propranolol treatment were significantly higher than in healthy controls. Serum FGF1 levels were higher in patients with IH, complicated hemangioma, and hemangioma receiving propranolol treatment than in healthy controls but the difference was not statistically significantly.
Conclusion |
Serum GLUT1, IGF-2, and VEGF-A levels were positively correlated with disease severity in patients with hemangioma, for example, in complicated hemangioma and hemangioma requiring propranolol treatment. However, further research on larger and different age subgroups is warranted to assess these markers.
Le texte complet de cet article est disponible en PDF.Keywords : GLUT1, IGF-2, VEGF-A, FGF 1, Infantile hemangioma
Plan
Vol 28 - N° 4
P. 296-300 - mai 2021 Retour au numéro
Article précédent
- Severity of parechovirus infections in infants under 3 months of age and comparison with enterovirus infections: A French retrospective study
- S. Marchand, E. Launay, I. Schuffenecker, C. Gras-Le Guen, B.-M. Imbert-Marcille, M. Coste-Burel
- Do children and adolescents with type 1 diabetes suffer from a lack of resources in France? Results from a benchmark study in the New Aquitaine region
- M.-N. Campas-Lebecque, S. Pochelu, V. Vautier, N. Bacheré, C. Beau, M. Benoit, B. Cammas, M. Carré, J. Chevrel, F. Compain, A. Fargeot-Espaliat, M. Franc, A. Galtier, C. Gambert, A. Lacoste, A. Lienhardt, L. Martineau, L. Oilleau, M. Percot-Blondy, A. Tamboura, A. Valade, P. Barat
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?